Hemoperfusion of pigs with a carbon-cellulose cartridge: a pilot study revealing a new animal model of extended anaphylactic shock

This pilot study establishes a new porcine model of irreversible anaphylactic shock by demonstrating that hemoperfusion with a carbon-cellulose cartridge (Adsorba® 300C) triggers a fatal, complement-mediated pseudoallergic reaction characterized by profound hemodynamic collapse, thereby providing a clinically relevant system to investigate extracorporeal circulation-induced immune responses.

The Gist

The Big Picture: A "Bad Date" with a Blood Filter

Imagine your body is a bustling city, and your blood is the traffic flowing through the streets. Sometimes, the city gets clogged with trash (toxins), and doctors need to send the blood out of the body, clean it, and send it back in. This is called extracorporeal circulation.

Usually, this process is like taking a car through a standard car wash: it gets clean, and the car drives away fine. But sometimes, the car wash is so aggressive that it damages the car, causing the engine to stall.

This study is about a specific type of "car wash" (a blood filter) that went terribly wrong. The researchers wanted to figure out why it caused a catastrophic reaction and to build a better way to test these filters before they hurt real people.

The Experiment: Pigs as Test Drivers

The researchers used pigs for this study. Why pigs? Because their hearts and immune systems react to foreign objects very similarly to humans. If a pig has a bad reaction, it's a huge red flag that a human might, too.

They set up a loop where the pig's blood was pumped out of its body, through a special filter, and back in. They tested three different types of filters:

1. The Oxygenator: Like a lung, it adds oxygen to the blood. (Safe).
2. The Hemofilter: Like a kidney, it filters out small waste. (Mostly safe).
3. The Adsorba® 300C: This is the "villain" of the story. It's a cartridge filled with activated charcoal (like the stuff in water filters) coated in cellulose. Its job is to grab onto toxins like a magnet.

What Happened? The "Perfect Storm"

When the blood went through the first two filters, the pig was fine. It was a smooth ride.

But when the blood hit the charcoal cartridge, the pig's body went into a state of total panic. Here is what happened, step-by-step:

1. The Alarm Bells (Complement Activation):
   Think of your immune system as a security team. When the blood touched the charcoal, the security team thought, "Intruder! Attack!" They sounded the alarm (releasing a chemical called C3a). This is called Complement Activation.

   • Analogy: Imagine walking into a building and the security guard mistakes your coat for a weapon and immediately calls the SWAT team.

2. The Chain Reaction:
   The alarm triggered the blood cells (white blood cells and platelets) to go crazy. They released a chemical called Thromboxane.

   • Analogy: The SWAT team didn't just arrest the intruder; they started shooting at the building's plumbing.

3. The Crash:
   This chemical storm caused two terrible things:

   • The Lungs Tightened: The blood vessels in the lungs squeezed shut (like a garden hose being stepped on), causing high pressure in the lungs.
   • The Body Leaked: The blood vessels in the rest of the body became leaky. The liquid part of the blood (plasma) leaked out into the tissues, leaving the blood thick and sludge-like (hemoconcentration).
   • The Result: The pig's blood pressure plummeted. The heart couldn't pump the thick sludge. The pig went into shock and, despite doctors trying to save it with adrenaline and CPR, it eventually died.

The "Aha!" Moment: Why Did This Happen?

The researchers realized the problem wasn't just that the filter was "foreign." The problem was the surface area.

• The Other Filters: Had a surface area about the size of a small towel.
• The Charcoal Filter: Had a surface area the size of a football field (because the charcoal is full of tiny microscopic holes).

The Metaphor:
Imagine you are trying to catch a fly.

• If you use a small net (the other filters), you might catch a few bugs, but the fly gets away.
• If you use a net the size of a football field made of sticky glue (the charcoal filter), you catch everything, including the air, the dust, and the fly. The sheer size of the "sticky surface" overwhelmed the pig's immune system, causing a massive, irreversible allergic reaction.

Why This Matters

1. It's a New Warning System: This study proves that pigs are the perfect "canary in the coal mine" for testing these medical devices. If a pig has a reaction, we know the device is dangerous for humans.
2. It Explains Past Tragedies: People have died or gotten very sick using this specific charcoal filter in the past. This study explains why: the surface area was too big, triggering a "pseudo-allergy" (an allergy without the usual allergy antibodies).
3. A New Model for Shock: The researchers created a new way to study fatal shock. Usually, animal models of shock are reversible (the animal wakes up). This model creates a "runaway" shock that keeps getting worse, which helps scientists test new drugs to stop this specific type of immune collapse.

The Takeaway

This paper tells us that when we design medical devices that touch our blood, bigger isn't always better. Sometimes, having too much surface area (like the charcoal filter) can trick the body's immune system into launching a self-destruct sequence.

The researchers successfully built a "crash test dummy" (the pig model) that can help engineers design safer filters in the future, potentially saving thousands of lives by preventing these rare but deadly reactions.

Technical Summary

1. Problem Statement

Extracorporeal circulation (ECC) procedures, such as hemoperfusion, hemodialysis, and cardiopulmonary bypass (CPB), are associated with adverse events (AEs) ranging from mild hypersensitivity to severe, life-threatening anaphylactoid reactions.

• Clinical Context: Carbon-cellulose hemoperfusion cartridges (e.g., Adsorba® 300C) are effective for toxin removal but are linked to severe adverse events in humans, including profound hypotension, thrombocytopenia, leukopenia, and shock. These reactions are often attributed to Complement Activation-Related Pseudoallergy (CARPA).
• The Gap: While CARPA is a known mechanism, there is a lack of clinically relevant large-animal models that can reproduce the irreversible, fatal anaphylactic shock observed in rare human cases. Existing models (mice, rats, guinea pigs) typically exhibit reversible reactions that resolve with intervention, failing to capture the sustained hemodynamic collapse seen in severe human cases. Furthermore, the specific role of surface area in triggering these reactions requires investigation.

2. Methodology

The study utilized a porcine model, chosen for its high sensitivity to complement-mediated reactions and physiological similarity to humans.

• Subjects: SPF Danbred pigs (20–28 kg).
• Experimental Setup:
  • Extracorporeal Circuit: Blood was circulated via a roller pump through the venous system (left jugular vein) and returned via the femoral vein.
  • Cartridges Tested:
    1. Adsorba® 300C: A cellulose-coated activated charcoal adsorbent (high surface area, ~200,000–400,000 m²).
    2. MultiFiltratePRO: A polysulfone hollow-fiber hemofilter (standard dialysis).
    3. Inspire 8 Start P: A polypropylene hollow-fiber oxygenator (CPB).
    4. Control: Extracorporeal circulation with no cartridge (tubing only) and PBS infusion.
• Monitoring Parameters:
  • Hemodynamics: Systemic Arterial Pressure (SAP) and Pulmonary Arterial Pressure (PAP) measured invasively.
  • Hematology: Complete blood counts (WBC, RBC, PLT), Hemoglobin (Hb), and Hematocrit (Ht).
  • Immune Markers: Plasma levels of complement fragment C3a and Thromboxane B2 (TXB2) (a stable metabolite of Thromboxane A2) measured via ELISA.
• Protocol: Blood flow was initiated at 0.15 L/min. Animals were monitored for 60 minutes or until hemodynamic collapse. Resuscitation attempts (norepinephrine, CPR) were performed on the test subject.

3. Key Contributions

1. Validation of Surface Area as a Rate-Limiting Factor: The study provides in vivo evidence that the massive surface area of carbon-based adsorbents is a critical driver of severe CARPA, far exceeding the reactivity of standard membrane-based devices (dialyzers/oxygenators).
2. Novel Animal Model of Fatal Shock: The authors established a new porcine model that replicates irreversible, self-perpetuating anaphylactic shock. Unlike previous models where shock is reversible, this model demonstrates a cycle of transient recovery followed by rapid relapse into shock despite aggressive resuscitation, mirroring fatal human cases.
3. Mechanistic Elucidation: The study confirmed the temporal sequence of CARPA: rapid Complement C3a release (humoral arm) followed by a delayed surge in Thromboxane B2 (cellular arm), confirming a causal link between complement activation and subsequent platelet/leukocyte activation leading to shock.

4. Results

A. Hemodynamic Responses

• Controls (PBS/Tubing): Induced only minor, transient hypotension (~20 mmHg drop) and negligible changes in PAP.
• Membrane Devices (Oxygenator/Dialyzer): Induced minor oscillations in SAP and PAP, well within background noise levels. No severe shock occurred.
• Adsorba® 300C (Carbon Cartridge):
  • Onset: After ~10 minutes of perfusion, the pig experienced an abrupt decline in SAP.
  • Progression: Within 8 minutes, the animal entered overt shock (profound hypotension) accompanied by maximal pulmonary hypertension.
  • Outcome: Despite administration of adrenaline, norepinephrine, and CPR, the animal experienced a "rebound" hypertension followed by rapid, irreversible relapse into shock and death.

B. Hematological Changes (Adsorba® 300C)

• Leukopenia & Thrombocytopenia: Severe and persistent drop in White Blood Cells (primarily granulocytes) and Platelets.
• Hemoconcentration: A paradoxical 28% increase in Hematocrit and Hemoglobin.
  • Interpretation: This indicates massive plasma extravasation (leakage) into the interstitial space and lungs, resulting in an estimated 31–37% loss of plasma volume (approx. 300–370 mL in a 25 kg pig). This fluid shift is a primary driver of the shock.

C. Immune Activation

• C3a Surge: A rapid, steep rise in plasma C3a occurred immediately upon contact with the charcoal surface, indicating massive complement activation.
• TXB2 Surge: A delayed, nearly 1000-fold increase in TXB2 followed the C3a peak.
• Correlation: The temporal dissociation confirms that C3a triggers the release of vasoactive mediators (Thromboxane A2) from platelets and macrophages, causing pulmonary vasoconstriction and systemic hypotension.

5. Significance and Implications

• Translational Relevance: The study bridges the gap between preclinical safety testing and clinical reality. It demonstrates that the pig model can predict severe, lethal reactions to extracorporeal devices that standard small-animal models might miss due to their reversible nature.
• Clinical Safety: The findings explain why carbon-based hemoperfusion cartridges (like Adsorba® 300C) have been withdrawn or restricted in some markets. The study highlights that the surface area of the device is a critical design parameter; larger surface areas exponentially increase the risk of CARPA.
• Therapeutic Development: This model provides a robust platform for testing:
  • New biocompatible coatings to prevent complement activation.
  • Prophylactic therapies (e.g., complement inhibitors) to prevent fatal shock in high-risk patients.
• Mechanistic Insight: The study reinforces the CARPA concept, showing that severe anaphylactoid reactions are driven by a specific cascade: Surface Contact $\rightarrow$ C3 Activation $\rightarrow$ Anaphylatoxin Release $\rightarrow$ Cellular Activation (Platelets/Leukocytes) $\rightarrow$ Mediator Release (TXA2) $\rightarrow$ Vascular Collapse.

In conclusion, this pilot study successfully characterizes a new, clinically relevant model of fatal anaphylactic shock induced by high-surface-area carbon hemoperfusion, offering critical insights for improving the safety of extracorporeal blood purification technologies.